Manoira specializes in the development of innovative products for the optimized treatment of companion animals and livestock, developed in-house or sublicensed from leading pharmaceutical partners. Its pipeline targets pain, inflammation, nausea, and anxiety, featuring a patented cocrystal form of cannabidiolic acid (CBDA) with enhanced thermal stability for species-specific applications. Backed by a 20-year solid-form patent, Manoira holds a strong intellectual property position and a sustainable competitive edge in the animal health sector.